Farallon Capital Management: Stock Portfolio, Performance and Latest Trades
13F portfolio value
$21.7B
89 holdings at Q2 2026
Get an email when Farallon Capital Management files a new 13F report
Free, no account needed. Unsubscribe with one click.
Farallon Capital Management's portfolio
As of Q2 2026, filed August 14, 2026 · prices as of October 8, 2026
| Company | Share of portfolio | Average buy price | Return | Current price | Last quarter |
|---|---|---|---|---|---|
| 14.9% | $34.94 | +438% | $188.12 | Reduced −0.4% | |
Electronic Arts Inc.285512109 | 9.51% | $204.23 | — | — | Added +6.0% |
| 4.68% | $40.03 | +62.5% | $65.04 | Added +15% | |
| 4.56% | $20.91 | +569% | $139.91 | No change | |
Exelixis Inc.EXEL | 4.29% | $22.85 | +158% | $59.02 | Added +2.7% |
Liquidia Corp.LQDA | 3.90% | $17.60 | +59.2% | $28.02 | Reduced −3.4% |
Amazon.com Inc.AMZN | 3.67% | $207.70 | +22.3% | $254.06 | Reduced −38% |
| 3.63% | $75.96 | +31.8% | $100.12 | No change | |
Natera Inc.NTRA | 3.52% | $69.61 | +461% | $390.79 | Reduced −31% |
| 3.09% | $451.60 | −17.9% | $370.95 | Reduced −30% | |
| 3.08% | $484.70 | +34.5% | $651.98 | Added +19% | |
| 2.96% | $26.90 | +27.2% | $34.21 | Added +48% | |
| 2.68% | $331.14 | −16.3% | $277.12 | Reduced −45% | |
| 2.63% | $68.60 | −38.7% | $42.04 | Added +41% | |
Broadcom Inc.AVGO | 2.55% | $343.37 | +4.9% | $360.14 | Reduced −35% |
Microsoft Corp.MSFT | 2.43% | $355.62 | +47.0% | $522.61 | Reduced −53% |
| 2.25% | $9.92 | +128% | $22.57 | Added +35% | |
| 2.21% | $113.60 | −21.2% | $89.56 | Reduced −12% | |
Synopsys Inc.SNPS | 2.17% | $445.61 | +11.7% | $497.75 | Reduced −32% |
| 2.06% | $39.95 | −38.4% | $24.60 | Added +1.0% | |
Crinetics Pharmaceuticals In22663K107 | 1.97% | $44.54 | — | — | Added +7.8% |
Grail Inc.GRAL | 1.66% | $56.93 | +133% | $132.61 | Added +28% |
Wabtec Corp.WAB | 1.41% | $146.34 | +91.9% | $280.80 | Reduced −44% |
Immunovant Inc.IMVT | 1.31% | $29.25 | +3.4% | $30.26 | Added +275% |
| 1.29% | $51.54 | +195% | $152.05 | Added +50% | |
| 1.29% | $28.88 | +10.5% | $31.92 | Added +4.1% | |
AramarkARMK | 1.21% | $33.85 | +64.1% | $55.54 | Reduced −41% |
| 0.81% | $120.83 | −30.5% | $83.92 | Added +171% | |
| 0.73% | $44.28 | −13.8% | $38.18 | Added +235% | |
| 0.73% | $22.56 | +26.2% | $28.48 | Added +143% | |
| 0.71% | $40.92 | +55.6% | $63.66 | Added +7.2% | |
| 0.64% | $189.95 | −16.4% | $158.78 | Added +153% | |
| 0.61% | $233.01 | +10.1% | $256.48 | Added +176% | |
Strategy Inc.Bond594972AS0 | 0.44% | — | — | — | Added +122% |
| 0.38% | $27.37 | +2.6% | $28.09 | New | |
| 0.33% | $149.91 | −4.5% | $143.11 | New | |
| 0.28% | $108.20 | +53.0% | $165.56 | Added +3928% | |
Vnet Group Inc.Bond90138AAE3 | 0.27% | — | — | — | No change |
| 0.27% | $15.74 | −14.7% | $13.43 | Added +173% | |
Joyy Inc-AdrJOYY | 0.27% | $47.94 | +68.6% | $80.85 | Added +21% |
| 0.26% | $23.18 | −1.6% | $22.82 | Added +31% | |
| 0.21% | $39.82 | −69.6% | $12.10 | Reduced −16% | |
| 0.19% | $32.24 | −19.7% | $25.88 | Added +197% | |
| 0.15% | $115.45 | +23.3% | $142.38 | Reduced −45% | |
| 0.15% | $24.76 | +0.8% | $24.95 | New | |
Freenome Inc.FRNM | 0.14% | $11.28 | +40.2% | $15.81 | No change |
| 0.14% | $21.98 | −54.5% | $10.00 | New | |
| 0.10% | $98.39 | −5.1% | $93.34 | Added +241% | |
| 0.10% | $30.08 | +9.1% | $32.81 | New | |
Abivax Sa-AdrABVX | 0.10% | $132.47 | −32.8% | $89.05 | Added +6000% |
Vnet Group Inc.VNET | 0.09% | $8.80 | −41.3% | $5.17 | Added +220% |
Netease Inc-AdrNTES | 0.09% | $124.07 | −3.6% | $119.60 | Reduced −58% |
Biogen Inc.BIIB | 0.09% | $191.29 | +14.2% | $218.43 | New |
| 0.09% | $5.92 | −25.1% | $4.43 | New | |
| 0.09% | $12.95 | −33.9% | $8.56 | New | |
Strategy Inc.Bond594972AN1 | 0.08% | — | — | — | New |
| 0.08% | $4.02 | −19.9% | $3.22 | No change | |
| 0.07% | $22.63 | +14.5% | $25.91 | New | |
Alvotech SAALVO | 0.06% | $4.13 | +37.1% | $5.67 | Added +1332% |
| 0.05% | $17.71 | −1.6% | $17.43 | Reduced −84% | |
Inflarx NVIFRX | 0.04% | $1.88 | −18.6% | $1.53 | New |
| 0.04% | $61.94 | −18.6% | $50.43 | New | |
| 0.03% | $21.03 | +25.9% | $26.48 | New | |
| 0.03% | $80.16 | −22.2% | $62.35 | New | |
Gentex Corp.GNTX | 0.03% | $23.65 | −10.6% | $21.15 | New |
| 0.03% | $560.90 | −8.5% | $513.14 | New | |
| 0.03% | $4.62 | −22.5% | $3.58 | No change | |
| 0.02% | $70.32 | −10.3% | $63.10 | New | |
| 0.02% | $10.63 | −0.7% | $10.56 | New | |
| 0.02% | $6.80 | +31.2% | $8.92 | New | |
Strategy Inc.Bond594972AU5 | 0.01% | — | — | — | New |
| 0.01% | $36.10 | −9.4% | $32.69 | No change | |
| 0.01% | $30.52 | +28.6% | $39.25 | Reduced −89% | |
| 0.01% | $0.33 | +2761% | $9.44 | No change | |
| 0.00% | $6.41 | +369% | $30.08 | No change | |
Aleanna Inc.ANNAW | 0.00% | $0.14 | +78.6% | $0.25 | No change |
Aleanna Inc.ANNA | 0.00% | $0.9536 | +167% | $2.55 | No change |
Welltower Inc.WELL | 0.00% | $186.78 | +19.4% | $223.04 | Reduced −100% |
| 0.00% | $2.29 | — | — | No change | |
Blue Gold Ltd.BGLWW | 0.00% | $0.4682 | −92.0% | $0.0375 | Reduced −15% |
| 0.00% | $10.13 | −77.3% | $2.30 | Reduced −89% | |
Geron Corp.GERN | 0.00% | $3.63 | −66.4% | $1.22 | Reduced −67% |
Nvni Group Ltd-28NVNIW | 0.00% | $0.0355 | −71.3% | $0.0102 | No change |
| 0.00% | $6.45 | −86.9% | $0.847 | Reduced −40% | |
| 0.00% | $1.35 | −41.3% | $0.792 | Reduced −73% | |
Beyond Meat Inc.08862E109 | 0.00% | $3.49 | — | — | No change |
Farallon Capital Management's options
As of Q2 2026. Value = shares the options cover.
| Company | Type | Value of shares covered | Last quarter |
|---|---|---|---|
| Put · bet on a fall or hedge | $4.5B | New | |
| Put · bet on a fall or hedge | $83.3M | New | |
CG Oncology Inc.CGON | Call · bet on a rise | $28.4M | New |
CG Oncology Inc.156944900 | Call · bet on a rise | — | Sold out |
Invesco S&P 500 Equal Weight46137V957 | Put · bet on a fall or hedge | — | Sold out |
SS Spdr S&P 500 ETF Trust-Us78462F953 | Put · bet on a fall or hedge | — | Sold out |
Farallon Capital Management's buys and sells
| Company | Action | Shares change | Value now |
|---|---|---|---|
| Reduced −23% | −2,640,000 | $4.8B | |
Pioneer Natural Resources Co.723787107 | Sold out | −3,520,000 | — |
| New | +4,250,000 | $862.3M | |
| New | +3,582,168 | $355.7M | |
| Added +197% | +1,243,200 | $550.5M | |
Catalent Inc.148806102 | Added +198% | +5,050,000 | $427.3M |
| Sold out | −2,594,356 | — | |
Hashicorp Inc Class A418100103 | New | +5,905,000 | $198.9M |
Alphabet Inc.GOOG | Reduced −46% | −1,541,410 | $329.5M |
| Added +51% | +994,670 | $757.6M | |
Moderna Inc.PutMRNA | New | +1,300,000 | $154.4M |
Stericycle Inc.858912108 | New | +2,560,000 | $148.8M |
| Added +30% | +2,249,820 | $378.7M | |
| Sold out | −626,854 | — | |
Natera Inc.NTRA | Added +14% | +532,874 | $483M |
| Added +3.1% | +86,870 | $618M | |
Vestis Corp.VSTS | Sold out | −4,914,753 | — |
| Added +54% | +796,000 | $183M | |
Astrazeneca Plc-Spons ADR046353108 | Added +65% | +950,000 | $187.9M |
| Sold out | −1,349,077 | — | |
Wabtec Corp.WAB | Reduced −26% | −766,900 | $346.1M |
| Added +1.1% | +63,900 | $243.8M | |
Nasdaq Inc.NDAQ | Reduced −11% | −930,000 | $452.4M |
Masimo Corp.574795100 | Reduced −25% | −370,000 | $141M |
Amgen Inc.AMGN | New | +232,000 | $72.5M |
| Reduced −9.8% | −411,030 | $336.2M | |
| Reduced −14% | −106,280 | $193.2M | |
United States Steel Corp.912909108 | Reduced −46% | −1,480,000 | $64.6M |
Intuit Inc.INTU | Added +17% | +92,019 | $413.4M |
| Reduced −17% | −439,700 | $143.8M | |
| Added +139% | +854,590 | $114.2M | |
TransunionTRU | Reduced −5.0% | −316,137 | $447.6M |
| Added +15% | +58,962 | $357.2M | |
| Reduced −7.3% | −58,260 | $408.8M | |
| Sold out | −500,000 | — | |
Geron Corp.GERN | Added +125% | +9,342,000 | $71.4M |
| Reduced −6.5% | −158,500 | $362.6M | |
| Reduced −9.8% | −50,390 | $204.2M | |
Insmed Inc.INSM | New | +568,000 | $38.1M |
| New | +200,800 | $36.6M | |
| Added +1.8% | +101,800 | $202.4M | |
| Added +75% | +3,401,370 | $185.4M | |
| Reduced −25% | −868,920 | $197.3M | |
Biohaven Ltd.BHVN | Added +181% | +1,449,000 | $78M |
| Sold out | −1,037,331 | — | |
| Reduced −99% | −729,200 | $228.8K | |
| New | +530,000 | $28.6M | |
Microsoft Corp.MSFT | Reduced −0.7% | −8,680 | $537.6M |
Amedisys Inc.AMED | Added +30% | +300,200 | $120.1M |
Cencora Inc.COR | Reduced −27% | −91,200 | $54.7M |
Championx Corp.15872M104 | New | +785,000 | $26.1M |
| Reduced −99% | −1,666,000 | $201.9K | |
| Added +21% | +141,036 | $215.7M | |
| Added +7.8% | +50,000 | $91.5M | |
| Reduced −11% | −1,268,219 | $508M | |
Exelixis Inc.EXEL | Added +1.6% | +424,000 | $609M |
| Sold out | −329,000 | — | |
Crinetics Pharmaceuticals In22663K107 | Added +9840% | +492,000 | $22.3M |
Sarepta Therapeutics Inc.CallSRPT | New | +133,300 | $21.1M |
| Added +30% | +33,000 | $45.6M | |
Apogee Therapeutics Inc.03770N101 | Sold out | −305,000 | — |
| Reduced −34% | −287,915 | $46M | |
Hess Corp.HES | Added +5.4% | +350,000 | $1B |
Humana Inc.HUM | Reduced −99% | −51,100 | $224.2K |
| Reduced −4.9% | −83,210 | $824.1M | |
| Reduced −99% | −1,754,000 | $241.8K | |
| Reduced −1.7% | −434,756 | $207.8M | |
Ascendis Pharma A/S04351P101 | Sold out | −109,000 | — |
Intra-Cellular Therapies Inc.46116X101 | Sold out | −231,000 | — |
Avidity Biosciences Inc.05370A108 | Reduced −99% | −601,061 | $204.3K |
Progyny Inc.PGNY | Added +121% | +715,900 | $37.4M |
Immunome Inc.IMNM | Sold out | −594,000 | — |
| Reduced −96% | −3,637,452 | $185K | |
Centessa Pharmaceuticals-Adr152309100 | Added +438% | +1,625,000 | $18M |
S&P Global Inc.SPGI | Reduced −1.5% | −11,910 | $348.7M |
| Reduced −16% | −253,190 | $293.3M | |
Screaming Eagle Acquisitn Co.G79407105 | Sold out | −1,000,000 | — |
Joyy Inc.Bond98426TAF3 | Sold out | −10,415,000 | — |
Elevation Oncology Inc.28623U101 | Reduced −7.4% | −288,245 | $9.7M |
Quanterix Corp.QTRX | Reduced −83% | −391,000 | $1.1M |
| New | +192,000 | $9.5M | |
Axonics Inc.05465P101 | Added +64% | +145,000 | $24.9M |
PG&E Corp.PCG | Reduced −46% | −579,319 | $12.1M |
Cazoo Group Ltd.CZOOF | Sold out | −714,240 | — |
Bruker Corp.BRKR | Sold out | −83,100 | — |
Airbnb Inc.ABNB | Added +5.8% | +92,780 | $257.9M |
| Sold out | −6,130,272 | — | |
| New | +431,010 | $7.1M | |
| Added +73% | +516,133 | $11.4M | |
Savara Inc.SVRA | Added +90% | +2,165,701 | $18.4M |
| Reduced −94% | −442,400 | $183.5K | |
Icon PLCICLR | Reduced −0.8% | −1,500 | $55.9M |
Vaxcyte Inc.PCVX | Reduced −23% | −87,400 | $21.9M |
Cerevel Therapeutics Holding15678U128 | Added +12% | +127,000 | $48.7M |
AramarkARMK | Reduced −5.0% | −893,700 | $575.9M |
Metals Acquisition Ltd-AG60409110 | Added +160% | +252,697 | $5.6M |
| Sold out | −50,000 | — | |
Biodesix Inc.09075X108 | New | +1,878,175 | $2.9M |
| Sold out | −151,768 | — | |
| Reduced −25% | −225,600 | $7.1M | |
| New | +108,799 | $2.3M | |
| Added +43% | +200,000 | $15.7M | |
Metals Acquisition Ltd-AG60409102 | Sold out | −825,000 | — |
| Reduced −11% | −487,500 | $316.4M | |
Soleno Therapeutics Inc.834203309 | Sold out | −27,750 | — |
Sunrun Inc.Bond86771WAB1 | Reduced −1.3% | −1,700,000 | $112.4M |
| New | +3,622 | $662.9K | |
Novavax Inc.NVAX | Reduced −67% | −753,750 | $4.8M |
| Reduced −90% | −134,999 | $35.6K | |
| Reduced −8.0% | −36,839 | $3.6M | |
Immunovant Inc.IMVT | New | +12,000 | $316.8K |
| New | +2,000 | $301.2K | |
| Sold out | −2,000 | — | |
| New | +3,600 | $246.6K | |
Springworks Therapeutics Inc.85205L107 | Sold out | −5,000 | — |
Merus NVN5749R100 | New | +4,000 | $236.7K |
Alpine Immune Sciences Inc.02083G100 | Sold out | −5,900 | — |
| Sold out | −2,800 | — | |
| Sold out | −5,000 | — | |
| New | +6,000 | $211.7K | |
| New | +30,000 | $193.5K | |
Screaming Eagle Acquisitn Co.G79407121 | Sold out | −333,330 | — |
Aeon Biopharma Inc.00791X118 | Sold out | −49,995 | — |
| Sold out | −450,000 | — | |
Lamf Global Ventures Corp. IG5338L124 | Sold out | −200,000 | — |
| New | +200,000 | $4.3K | |
| Sold out | −150,000 | — |
Farallon Capital Management's portfolio by sector
Share of the stock portfolio at Q2 2026.
| Sector | Share |
|---|---|
| Health Care | 62% |
| Technology | 12% |
| Other | 12% |
| Financials | 8.1% |
| Consumer Discretionary | 5.0% |
| Industrials | 1.5% |
| Materials | 0.3% |
| Energy | 0.0% |
| Real Estate | 0.0% |
Portfolio performance: Farallon Capital Management vs. benchmarks
Your result if you had bought each reported portfolio on the day it was made public and held it until the next report, against the S&P 500 and Nasdaq-100.
- You, copying after each 13F filing – estimated value
- S&P 500
- Nasdaq-100
| Total return | Per year | |
|---|---|---|
| You, copying after each 13F filing – estimated value | +56.8% | +9.4% |
| S&P 500 | +89.0% | +13.6% |
| Nasdaq-100 | +113.3% | +16.4% |
Prices were available for 56% of the portfolio value on average; the rest is left out of the return.
Farallon Capital Management's most traded stocks
Quarters with a buy or a sell, all reports since Q2 2013.
| Company | Quarters bought | Quarters sold |
|---|---|---|
Microsoft Corp.MSFT | 25 | 27 |
Alphabet Inc.GOOG | 19 | 24 |
| 19 | 22 | |
Wabtec Corp.WAB | 20 | 18 |
Exelixis Inc.EXEL | 21 | 16 |
TransunionTRU | 15 | 20 |
| 20 | 13 | |
| 18 | 11 | |
Grifols Sa-AdrGRFS | 14 | 14 |
| 15 | 12 | |
| 10 | 17 | |
| 15 | 11 | |
| 16 | 10 | |
| 14 | 12 | |
| 13 | 12 |